Abstract
Medical journals hold an exalted position in medicine, but have many shortcomings. This perspective reviews some of the shortcomings of medical journals which are primarily related to inexperience, bias, and commercialism. The issues discussed include the uncertain mission of the traditional medical journal in the modern digital age, the inherent inexperience of voluntary editorial boards, the weaknesses and capricious nature of decisions made by the peer-review process, the uneven value of most journal articles, the bias in what gets submitted and published in journals, the misunderstanding about the criteria for authorship, the misunderstanding of the need for ethical review board approval of studies, the misunderstanding of the need for informed consent for research from patients and ethical review boards, the various sources of assistance to editors and authors in dealing with the many ethical issues arising in the publication process, the commercialization and manipulation of medical journals by industry, the prevalent and complex financial entanglements of authors with industry, and the imperfect impact factor, which has the potential to be abused. The perspective concludes with theorization of the role of medical journals in the future. Readers need to scrutinize data in the literature carefully and interpret the discussions and conclusions critically, as there are biases in what is published in medical journals.
Similar content being viewed by others
Abbreviations
- IF:
-
impact factor
- WoS:
-
Web of Science
- Equation:
-
Eq
References
Association of American Medical Colleges (AAMC) (2007) The Scientific Basis of Influence and Reciprocity: a Symposium; 2007 Jun 12; Washington, DC. AAMC
Angell M (2008) Industry-sponsored clinical research: a broken system. JAMA 300: 1069-1071
Bhopal R, Rankin J, McColl E et al (1997) The vexed question of authorship: views of researchers in a British medical faculty. BMJ 314: 1009-1012
Bressler NM, Liesegang TJ, Schachat AP et al (2004) Advantages and potential dangers of presentation before publication: third in a series on editorship. Arch Ophthalmol 122: 1045-1048
Committee on Publication Ethics (COPE) (2004) A code of conduct for editors of biomedical journals. Available via http://publicationethics.org/code-conduct. Accessed 2005 Aug 22
Davidoff F, DeAngelis CD, Drazen JM et al (2001) Sponsorship, authorship, and accountability. Lancet 358: 854-856
DeAngelis C (2006) The influence of money on medical science. JAMA 296: 996-998
De Angelis C, Drazen JM, Frizelle FA et al (2004) Clinical trial registration: a statement from the International Committee of Medical Journal Editors. N Engl J Med 351: 1250-1251
Dickersin K (1990) The existence of publication bias and the risk factors for its occurrence. JAMA 263: 1385-1389
Dickersin K, Min YI (1993) Publication bias: the problem that won’t go away. Ann NY Acad Sci 703: 135-146
Editorship Series in Ophthalmology. Available via http://ajo.com/content/editorship Accessed 27 Feb 2009
Egger M, Bartlett C, Juni P (2001) Are randomized controlled trials in the BMJ different?. BMJ 323: 1253-1254
Flanagin A, Carey LA, Fonanarosa PB et al (1998) Prevalence of articles with honorary authors and ghost authors in peerreviewed medical journals. JAMA 280: 222-224
Fontanarosa PB, Flanagin A, DeAngelis DC (2005) Reporting conflicts of interest, financial aspects of research, and role of sponsors in funded studies. JAMA 294: 110-111
Freeman WR (2005) Control of data, authorship, and responsibility for clinical trials publications. Ophthalmology 112: 1485-1486
Godlee F (2004) Dealing with editorial misconduct. BMJ 329: 1301-1302
Godlee F, Jefferson T (eds) (2003) Peer review in health sciences, 2nd edn. BMJ Books, London
Gottlieb S (2002) Congress criticizes drugs industry for misleading advertising. BMJ 325: 1379
Horton R (2002) The hidden research paper. JAMA 287: 2775-2778
Institute of Medicine (2001) Crossing the quality chasm. A new health system for the 21st century. Washington, The National Academies. Available via http://www.iom.edu/CMS/8089/5432.aspx. Accessed 17 Feb 2009
Institute of Medicine (2002) Responsible research: A systems approach to protecting research participants. Washington: National Academy of Sciences. Available via http://www.iom.edu/CMS/3740/4870/4459.aspx. Accessed 27 Feb 2009
Institute of Medicine (2009) Beyond the HIPAA privacy rule: Enhancing privacy, improving Health through research. Washington. The National Academies. Available via http://www.iom.edu/CMS/3740/43729/61796.aspx. Accessed 27 Feb 2009
Ioannidis JP (2005) Why most published research findings are false. PloS Med 2:e124
Jabs DA (2005) Improving the reporting of clinical case series. Am J Ophthalmol 139: 900-905
Kjaergard LL, Als-Nielsen B (2002) Association between competing interests and authors-conclusions: epidemiological study of randomised clinical trials published by the BMJ. BMJ 325: 249
Levin LA, Gottlieb JL, Beck RW et al (2005) Registration of clinical trials. Arch Ophthalmol 123: 1263-1264
Lexchin J, Bero LA, Djulbegovic B et al (2003) Pharmaceutical industry sponsorship and research outcome and quality: systemic review. BMJ 326: 1167-1170
Lichter PR (2008) Debunking myths in physician-industry conflicts of interest. Am J Ophthalmol 146: 159-171
Liesegang TJ (2007a) Institutional review boards and new patient privacy issues in publication. Indian J Ophthalmol 55: 169-171
Liesegang TJ (2007b) The meaning and need for informed consent in research. Indian J Ophthalmol 55: 1-3
Liesegang TJ (2007c) Web 2.0, Library 2.0, Physician Learning 2.0. Ophthalmology 114: 1801-1083
Liesegang TJ (2008) Commercialism, loss of professionalism, and the effect on journals. Arch Ophthalmol 126: 1292-1295
Liesegang TJ, Albert DM, Schachat AP (2008) How to ensure our readers-trust: the proper attribution of authors and contributors. Am J Ophthalmol 146: 337-340
Liesegang TJ, Albert DM, Schachat AP (2008) Not for your eyes: information concealed through publication bias. Am J Ophthalmol 146: 638-640
Liesegang TJ, Schachat AP, Albert DM (2005a) Pharmaceutical companies and ophthalmic research. Ophthalmology 112: 363-365
Liesegang TJ, Schachat AP, Albert DM (2005b) The Open Access initiative in scientific and biomedical publishing: Fourth in the series on editorship. Am J Ophthalmol 139: 156-167
Liesegang TJ, Shaikh M, Crook JE (2007) The outcome of manuscripts submitted to the American Journal of Ophthalmology between 2002 and 2003. Am J Ophthalmol 143: 551-560
Lock S (1991) A difficult balance: editorial peer review in medicine, 3rd edn. British Medical Journal, London
Olson CM, Rennie D, Cook D et al (2001) Publication bias in editorial decision making. BMJ 323: 2825-2828
Pich J, Came X, Amaiz JA et al (2003) Role of research ethics committee in follow-up and publication of results. Lancet 361: 1015-1016
Relman AS (1981) The Ingelfinger rule. N Engl J Med 305: 824-826
Rennie D (1986) Guarding the guardians: a conference on editorial peer review. JAMA 256: 2391-2392
Rennie D (1997) Thyroid storm. JAMA 277: 1238-1243
Rennie D, Yank V, Emanuel L (1997) When authorship fails. A proposal to make contributors accountable. JAMA 278: 579-585
Schroter S, Black N, Evans S et al (2004) Effects of training on quality of peer review: randomized controlled trial. BMJ 328: 673
Scott-Lichter D and the Editorial Policy Committee, Council of Science Editors (2006) CSE’s White Paper on Promoting Integrity in Scientific Journal Publications. Reston,Va: CSE. Available via http://www.councilscienceeditors.org/editorial_policies/white_paper.cfm. Accessed 27 Feb 2009
Shapiro DW, Wenger WS, Shapiro MF (1994) The contributions of authors to multiauthored biomedical research papers. JAMA 271: 438-442
Seglen PO (1997) Why the impact factor of journals should not be used for evaluating research. BMJ 314: 498-402
Seglen PO (1994) Causal relationship between article citedness and journal impact. J Am Soc Inf Sci 45: 1-11
Smith R (2005) Medical journals are an extension of the marketing arm of pharmaceutical companies. PLoS Med 2:e138
Smith R (2006) The Trouble with Medical Journals. Royal Society of Medicine Press Ltd, London
The International Committee of Medical Journal Editors (ICJME) (2008) Uniform requirements for manuscripts submitted to biomedical journals: writing and editing for biomedical publication. Available via http://www.icmje.org/. Accessed 10 Feb 2009
Utiger RD (2001) WAME Syllabus for Prospective and Newly Appointed Editors. Available via http://www.wame.org/resources/editor-s-syllabus/. Accessed 27 Feb 2009
Villaneuva P, Peiro S, Librero J et al (2003) Accuracy of pharmaceutical advertisements in the medical journals. Lancet 361: 27-32
Wilkes MS, Doblin BH, Shapiro MF (1992) Pharmaceutical advertisements in leading medical journal: experts-assessments. Ann Intern Med 116: 912-919
World Association of Medical Editors (WAME) (2009) WAME publication ethics policies for medical journals. Available via http://www.wame.org/resources/publication-ethics-policies-for-medical-journals/. Accessed 27 Feb 2009
World Medical Association (WMA) (2008) Declaration of Helsinki. Ethical principles for medical research involving human subjects. Available via http://www.wma.net/e/policy/b3.htm . Accessed 27 Feb 2009
Author information
Authors and Affiliations
Corresponding author
Additional information
The editors dedicate this article to the memory of Prof. Ludwik Hirszfeld, founder of the Institute of Immunology and Experimental Therapy, Polish Academy of Sciences (Wrocław, Poland) and its two journals (Postępy Higieny i Medycyny Doświadczalnej in 1949, Archivum Immunologiae et Therapiae Experimentalis in 1953), who died fifty-five years ago.
About this article
Cite this article
Liesegang, T.J. Revealing the faults in medical journals. Arch. Immunol. Ther. Exp. 57, 75–83 (2009). https://doi.org/10.1007/s00005-009-0012-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00005-009-0012-2